Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (431-440 of 543) with videos related to

Pageof 55
Sort By:
Human Molecular Genetics|June 17, 2004
Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseasesRemko de Pril, David F Fischer, Marion L C Maat-Schieman, et al.
Biotechnology and Bioengineering|September 13, 2002
Modelling of the enzymatic kinetically controlled synthesis of cephalexin: influence of diffusion limitationC G P H Schroën, C B Fretz, V H DeBruin, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 1, 2013
Texture analysis of ultrahigh field T2*-weighted MR images of the brain: application to Huntington's diseaseNhat Trung Doan, Simon J A van den Bogaard, Eve M Dumas, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Journal of Neurology|December 7, 2011
Deficient sustained attention to response task and P300 characteristics in early Huntington's diseaseE P Hart, E M Dumas, R H A M Reijntjes, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2003
Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline studyMarie-Noëlle W Witjes-Ané, Maria Vegter-van der Vlis, Jeroen P P van Vugt, et al.
Journal of Neurology|January 22, 2009
Basal ganglia volume and clinical correlates in 'preclinical' Huntington's diseaseCaroline K Jurgens, Lotte van de Wiel, Ad C G M van Es, et al.
The American Journal of Pathology|February 2, 2011
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinomaFrederik C Roos, Andrew J Evans, Walburgis Brenner, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Pageof 55

Showing results (431-440 of 543) with videos related to

Sort By:
Pageof 55
Human Molecular Genetics|June 17, 2004
Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseasesRemko de Pril, David F Fischer, Marion L C Maat-Schieman, et al.
Biotechnology and Bioengineering|September 13, 2002
Modelling of the enzymatic kinetically controlled synthesis of cephalexin: influence of diffusion limitationC G P H Schroën, C B Fretz, V H DeBruin, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 1, 2013
Texture analysis of ultrahigh field T2*-weighted MR images of the brain: application to Huntington's diseaseNhat Trung Doan, Simon J A van den Bogaard, Eve M Dumas, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Journal of Neurology|December 7, 2011
Deficient sustained attention to response task and P300 characteristics in early Huntington's diseaseE P Hart, E M Dumas, R H A M Reijntjes, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2003
Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline studyMarie-Noëlle W Witjes-Ané, Maria Vegter-van der Vlis, Jeroen P P van Vugt, et al.
Journal of Neurology|January 22, 2009
Basal ganglia volume and clinical correlates in 'preclinical' Huntington's diseaseCaroline K Jurgens, Lotte van de Wiel, Ad C G M van Es, et al.
The American Journal of Pathology|February 2, 2011
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinomaFrederik C Roos, Andrew J Evans, Walburgis Brenner, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Pageof 55